Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03530826 · ClinicalTrials.gov registry record

A Crowd Sourcing Platform for Patients With Cancer

A clinical trial of Cancer, sponsored by All4Cure.

Recruiting
Registry status
5,000
Enrollment target
1
Study location

NCT03530826 is a study of Cancer that is actively recruiting participants, run by All4Cure. The registered enrollment target is 5,000 participants, above the 3,483-participant average among 615 other Cancer trials with a reported enrollment target (44% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03530826, a study of Cancer, is actively recruiting participants, sponsored by All4Cure.

RECRUITING
Registry status
5,000 participants
Enrollment target
1
Study location

Study Summary

All4Cure aims to accelerate learning about cancer by sharing medical information and research results from cancer patients with fellow cancer patients, oncologists, and scientists on the All4Cure website with the hope that together patients, clinicians and researchers can cure cancer faster.

Conditions Studied

Interventions

  • OTHER No intervention

Study Locations (1)

Washington

  • All4Cure - Seattle

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2018-04-26
Est. Completion 2028-01-31

Sponsor

All4Cure

3 total trials

What the Registry Record Tells You About NCT03530826

The ClinicalTrials.gov registry entry for NCT03530826 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,483-participant average among 615 other Cancer trials with a reported enrollment target (44% higher). The listed sponsor is All4Cure, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.

NCT03530826 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT03530826 about?

NCT03530826 is a clinical study titled "A Crowd Sourcing Platform for Patients With Cancer". All4Cure aims to accelerate learning about cancer by sharing medical information and research results from cancer patients with fellow cancer patients, oncologists, and scientists on the All4Cure website with the hope that together patients, clinicians and researchers can cure cancer faster.

What is the current status of trial NCT03530826?

This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2018-04-26. Estimated completion is 2028-01-31.

What conditions does trial NCT03530826 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT03530826?

The interventions under investigation include: No intervention (OTHER).

Who is sponsoring clinical trial NCT03530826?

This trial is sponsored by All4Cure, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03530826 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.